Searching... Searching...
  • NVP -2.99%
  • Köp 1.36
  • Sälj 1.38
  • Senast 1.36
  • SEK

  • NEVPF +NA
  • Buy NA
  • Sell NA
  • Latest NA
  • USD

Company presentations

 

NeuroVive’s research currently covers four segments where the company’s in-depth mitochondrial know-how has the potential to make a substantial improvement to care: Genetic Mitochondrial Diseases, Traumatic Brain Injury (TBI), Non-Alcoholic Steatohepatitis (NASH) and Hepatocellular Carcinoma (HCC).

Please click the fact sheet to find out more about the company and its pipeline.

NeuroVive Factsheet October 2017

Factsheet


Stora Aktiedagen Stockholm 2018, 26 November


Analysts' lunch at Cord Communications in Stockholm, 22 November 2018.


The LSX Inv€$tival Showcase and the Jefferies 2018 Healthcare Conference, 13 – 15 November


Finwire.Tv – NeuroVive Sitdown – interview with CEO Erik Kinnman


Aktiespararna – Kvinnokvällen, Gothenburg

15 October 2018. Chief Financial Officer & Vice President Investor Relations Catharina Johansson and CEO Erik Kinnman presneted the company.


LSX Nordic Congress, Stockholm

30 August 2018


NeuroVive's presentation at BioStock Live in Lund, 18 April 2018


Financial Hearings' interview with CEO Erik Kinnman


2nd Annual H.C. Wainwright NASH Investor Conference, New York, 19 March 2018

Live webcast at 11.20 local time


Stockholm Corporate Finance Life Science Seminarium, 7 March 2018


NeuroVive at Aktiedagen in Lund, 30 January 2018


 10th Annual Conference – Biotech Showcase 2018, San Francisco

8 January 2018 at 4:00 p.m. local time (PST), 9 January 2018 at 1:00 a.m. Swedish time (CET). Registration required.


Executive interview by EdisonTV


CEO Erik Kinnman presents at the 2017 Biotech and Money Inv€$tival Showcase Conference in London


Mitochondria Day, 19 September 2017, Stockholm, Sweden


Börsveckans Småbolagsdag, 23 August 2017, Stockholm, Sweden


Mitochondrial Medicine Focus Drives NeuroVive Orphan Ambitions

Interview with CEO Erik Kinnman, Scrip Pharma intelligence, 18 May 2017


Aktiespararna's Aktiedag Stockholm, 15 May 2017

View CEO Erik Kinnman's presentation here:


Web cast on in-licensing agreement with Yungjin Pharm, 3 May 2017, at 2:00 pm CEST

Erik Kinnman, CEO, and Magnus Hansson, CMO, will be presenting and will be available for questions after the presentation.

 


9th Annual Conference – Biotech Showcase 2017, San Francisco

10 January 2017 at 5:00 p.m. local time (PST), 11 January 2017 at 2:00 a.m. Swedish time (CET). Registration required.

 


Stora Aktiedagen, 28 November 2016, Stockholm, Sweden

View CEO Erik Kinnman's presentation here:

 


 

Webcast for presentation of the CiPRICS study results
October 13, 2016 at 3.00 p.m. CEST.

To call in please use one of the following numbers: Sweden: +46856642690 UK: +442030089815 US: +18558315946.


Rodman & Renshaw 18th Annual Global Investment Conference
September 13, 2016 at 5:05 p.m. EDT /11:05 p.m. CEST.


 

NeuroVive's presentation at BioStock Live Roadshow, 20 April (In Swedish)

 


 

 


 

Comments are closed.